Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ503503,5-0,20
KB798799,50,00
PKN87,6487,64-6,91
Msft150,25150,450,23
Nokia3,1523,1590,51
IBM131,95133,490,00
Daimler AG48,948,91-0,71
PFE38,0538,20,03
06.12.2019 13:19:58
Indexy online
AD Index online
select
AD Index online
 

  • 05.12.2019
ResMed (RMD, NY Consolidated)
Závěr k 5.12.2019 Změna (%) Změna (USD) Objem obchodů (ks)
150,18 0,02 0,03 516 724
Premarket06.12.2019 13:00:00
Poslední obchod Nákup / Prodej Změna (%) Změna (USD) Objem obchodů (ks)
- 147,30 152,00 - - -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 06.12.2019
Popis společnosti
Obecné informace
Název společnostiResMed Inc.
TickerRMD
Kmenové akcie:Ordinary Shares
RICRMD
ISINUS7611521078
Poslední známé roční výsledky30.06.2019
Poslední známé čtvrtletní výsledky30.09.2019
Počet zaměstnanců k 30.06.2019 7 240
Akcie v oběhu k 21.10.2019 143 786 123
Počet akcionářů k 30.06.2019 20
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice9001 Spectrum Center Blvd
MěstoSAN DIEGO
PSČ92123-1438
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 587 462 400
Fax13026365454

Business Summary: ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.
Financial Summary: BRIEF: For the three months ended 30 September 2019, ResMed Inc. revenues increased 16% to $681.1M. Net income before extraordinary items increased 13% to $120.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Selling, general and administrative increase of 14% to $167.4M (expense), Research and development increase of 24% to $48M (expense).
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology - NEC
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSOffices of Other Holding Companies
SICSurgical And Medical Instruments
SICElectromedical Equipment
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies
SICHolding Companies, Nec



  • Poslední aktualizace: 06.12.2019
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Operating OfficerRobert Douglas5901.03.2013
Chief Executive Officer, DirectorMichael Farrell4701.03.2013
Chief Financial OfficerBrett Sandercock5201.01.2006
President – Sleep BusinessJim Hollingshead5601.03.2013
President – Respiratory Care BusinessRichard McHale55
President – Software as a Service Business (SaaS)Raj Sodhi46
Chief Administrative Officer, Global General Counsel, SecretaryDavid Pendarvis6023.05.2011